APA

Baselga J., Segalla J. G. M., Roché H., Del Giglio A., Pinczowski H., Ciruelos E. M., Filho S. C., Gómez P., Van Eyll B., Bermejo B., Llombart A., Garicochea B., Durán M. Á. C., Hoff P. M. G., Espié M., de Moraes A. A. J. G., Ribeiro R. A., Mathias C., Gil Gil M., Ojeda B., Morales J., Kwon Ro S., Li S. & Costa F. (20120629). Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Baselga José, Segalla José Getúlio Martins, Roché Henri, Del Giglio Auro, Pinczowski Hélio, Ciruelos Eva M, Filho Sebastião Cabral, Gómez Patricia, Van Eyll Brigitte, Bermejo Begoña, Llombart Antonio, Garicochea Bernardo, Durán Miguel Ángel Climent, Hoff Paulo Marcelo Gehm, Espié Marc, de Moraes Andre Augusto Junior Gemeinder, Ribeiro Ronaldo Albuquerque, Mathias Clarissa, Gil Gil Miguel, Ojeda Belén, Morales Josefa, Kwon Ro Sunhee, Li Shell and Costa Frederico. 20120629. Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Baselga J., Segalla J. G. M., Roché H., Del Giglio A., Pinczowski H., Ciruelos E. M., Filho S. C., Gómez P., Van Eyll B., Bermejo B., Llombart A., Garicochea B., Durán M. Á. C., Hoff P. M. G., Espié M., de Moraes A. A. J. G., Ribeiro R. A., Mathias C., Gil Gil M., Ojeda B., Morales J., Kwon Ro S., Li S. and Costa F. (20120629). Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Baselga José, Segalla José Getúlio Martins, Roché Henri, Del Giglio Auro, Pinczowski Hélio, Ciruelos Eva M, Filho Sebastião Cabral, Gómez Patricia, Van Eyll Brigitte, Bermejo Begoña, Llombart Antonio, Garicochea Bernardo, Durán Miguel Ángel Climent, Hoff Paulo Marcelo Gehm, Espié Marc, de Moraes Andre Augusto Junior Gemeinder, Ribeiro Ronaldo Albuquerque, Mathias Clarissa, Gil Gil Miguel, Ojeda Belén, Morales Josefa, Kwon Ro Sunhee, Li Shell and Costa Frederico. Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20120629.